A detailed history of Russell Investments Group, Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 15,818 shares of HROW stock, worth $677,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,818
Holding current value
$677,959
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$20.85 - $46.47 $329,805 - $735,062
15,818 New
15,818 $711,000
Q3 2023

Nov 13, 2023

SELL
$14.03 - $22.08 $1.84 Million - $2.9 Million
-131,324 Reduced 99.98%
23 $0
Q2 2023

Aug 10, 2023

BUY
$17.37 - $28.08 $1.84 Million - $2.98 Million
106,124 Added 420.74%
131,347 $2.5 Million
Q1 2023

May 09, 2023

SELL
$13.84 - $21.46 $407,934 - $632,533
-29,475 Reduced 53.89%
25,223 $533,000
Q4 2022

Feb 08, 2023

SELL
$10.28 - $14.78 $661,990 - $951,772
-64,396 Reduced 54.07%
54,698 $807,000
Q3 2022

Nov 04, 2022

SELL
$6.57 - $24.88 $19,604 - $74,241
-2,984 Reduced 2.44%
119,094 $1.44 Million
Q2 2022

Jul 29, 2022

SELL
$5.75 - $7.74 $1.74 Million - $2.35 Million
-303,144 Reduced 71.29%
122,078 $887,000
Q1 2022

May 05, 2022

BUY
$6.77 - $8.66 $946,351 - $1.21 Million
139,786 Added 48.97%
425,222 $2.9 Million
Q4 2021

Jan 21, 2022

BUY
$8.5 - $12.0 $2.43 Million - $3.43 Million
285,436 New
285,436 $2.46 Million
Q4 2020

Feb 08, 2021

SELL
$4.76 - $6.93 $141,600 - $206,153
-29,748 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$4.71 - $7.36 $140,113 - $218,945
29,748 New
29,748 $166,000
Q2 2020

Aug 05, 2020

SELL
$3.61 - $6.47 $24,584 - $44,060
-6,810 Closed
0 $0
Q1 2020

May 06, 2020

SELL
$3.5 - $7.31 $48,335 - $100,951
-13,810 Reduced 66.97%
6,810 $28,000
Q4 2019

Jan 29, 2020

SELL
$4.6 - $7.88 $2,369 - $4,058
-515 Reduced 2.44%
20,620 $158,000
Q1 2019

May 13, 2019

BUY
$4.75 - $7.1 $100,391 - $150,058
21,135 New
21,135 $101,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.16B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.